相关实验视频

Updated: Jan 15, 2026

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Published on: August 9, 2019

人类CD34⁺HSPC衍生中性粒细胞的表征,具有有限的髓衍生免疫抑制细胞活性

Steven D S Webbers^1,2, Angela A F Gankema^1,2, Fleur van Oosterom^1,2

¹Department of Molecular Hematology, Sanquin Research, University of Amsterdam, 1066 CX Amsterdam, the Netherlands.

|October 7, 2025

概括

研究人员培养出血源性干细胞和原始细胞衍生的中性粒细胞,发现它们在功能和表型上密切模仿血液中性粒细胞. 这些培养中性粒细胞为研究和潜在的输血产品提供了有希望的模型,其免疫抑制活性降低.

科学领域:

血液学血液学血液学
免疫学免疫学免疫学
细胞生物学细胞生物学

背景情况:

中性粒细胞是重要的免疫细胞,但寿命短,限制了它们在研究和输血产品中的使用.
目前用于中性粒细胞研究和治疗应用的现有方法受到细胞活力和功能限制的限制.

研究的目的:

开发一种方法,从CD34+造血干细胞和原生细胞 (HSPCs) 中培养中性粒细胞.
为了比较培养中性粒细胞与外围血液中性粒细胞的形态,表型和功能.
评估培养中性粒细胞作为研究模型和输血产品的潜力.

主要方法:

隔离和培养CD34+的HSPCs.
将HSPC分化为中性粒细胞.
形态,表型 (CD15,CD11b,CD16) 和功能测定 (杀死微生物,ADCC,MDSC活动).
转录和蛋白质组分析以与血液中性粒细胞进行比较.

主要成果:

培养中性粒细胞表现出成熟的形态和表达了关键的表面标记物 (CD15+,CD11b+,CD16高).
功能性测试显示了微生物杀伤能力和抗体依赖细胞细胞毒性 (ADCC),与血液中性粒细胞相比.
培养中的中性粒细胞显示出髓质衍生抑制细胞 (MDSC) 活性的缺陷,与明显的颗粒组成有关.
培养和血液中性粒细胞之间的转录和蛋白质丰度模式具有很高的相似性.

结论:

CD34+ HSPC衍生的中性粒细胞在关键特征上与外周血液中性粒细胞非常相似.
培养中性粒细胞为基础研究提供了一个可行的替代方案,也是输血产品的潜在来源.
培养中性粒细胞的降低免疫抑制活性是输血应用的理想功能性质.

关键词:

免疫学免疫学免疫学蛋白质组学是指蛋白质组学.文字转录学 (Transcriptomics) 是一个学科.

更多相关视频

Isolation and Characterization of Neutrophils with Anti-Tumor Properties

Isolation and Characterization of Neutrophils with Anti-Tumor Properties

Published on: June 19, 2015

Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells

Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells

Published on: November 1, 2017

相关概念视频

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...